Effect of TU-100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Constipation
NCT01139216 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2013-01-14
Summary
The purpose of this study is to assess the dose-related effects of TU-100, a botanical agent that modulates gastrointestinal nerves, on rectal compliance, rectal sensation thresholds and small bowel and colonic transit in female patients with functional constipation as compared to placebo.
Conditions
- Functional Constipation
- Gastric Emptying
- Whole Gut Transit
- Small Bowel Transit
- Colonic Transit
- Rectal Compliance
- Rectal Sensation
Interventions
- DRUG
-
Daikenchuto (TU-100)
Subjects will receive 2.5g TID (7.5g/day) of TU-100. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 4 weeks.
- DRUG
-
Daikenchuto (TU-100)
Subjects will receive 5g TID (15g/day) of TU-100. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 4 weeks.
- DRUG
-
Subjects will receive daily dose of TU-100 placebo. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 4 weeks.
Sponsors & Collaborators
-
Cato Research
collaborator INDUSTRY -
Tsumura USA
lead INDUSTRY
Principal Investigators
-
Michael Camilleri, MD · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2012-11-30
- Completion
- 2012-11-30
Countries
- United States
Study Locations
More Related Trials
-
Effects of Lactulose on Gut Microbiota and Metabolism in Diabetic Constipated Patients
NCT07065942 ·Status: RECRUITING ·Phase: NA
-
Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals
NCT02649062 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation
NCT02137642 ·Status: COMPLETED ·Phase: PHASE1
-
Congrong Runtong Oral Liquid in the Treatment of Functional Constipation (Yang-deficiency Type)
NCT05803161 ·Status: COMPLETED ·Phase: PHASE2
-
BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
NCT02819297 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Responsive Effect of Polydextrose on Whole Gut Transit Time
NCT01540669 ·Status: TERMINATED ·Phase: NA
-
Lubiprostone, Colonic Motility and Sensation
NCT00953043 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
NCT02819310 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy
NCT02123017 ·Status: COMPLETED ·Phase: PHASE2
-
Bowel Function After Minimally Invasive Urogynecologic Surgery
NCT01044212 ·Status: COMPLETED ·Phase: NA
-
Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation
NCT02784093 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of the Effect of Chicory Inulin-type Fructans in Constipated Adults
NCT05447481 ·Status: COMPLETED ·Phase: NA
-
Daikenchuto for Intestinal Dysmotility and Prevention of Postoperative Paralytic Ielus After Pancreaticoduodenectomy
NCT01607307 ·Status: UNKNOWN ·Phase: PHASE2
-
Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients
NCT00153153 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Pyridostigmine for Constipation in Diabetics
NCT00276406 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
NCT02481947 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults
NCT01687985 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Effect of Rhubarb Extract on Stool Frequency and Biological Markers of Intestinal Function in Seniors With Low Defecation
NCT05541991 ·Status: COMPLETED ·Phase: NA
-
Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation
NCT00153140 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation
NCT00306748 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated Adults
NCT00583154 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation
NCT02822508 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation
NCT02314936 ·Status: COMPLETED ·Phase: PHASE2
-
Laxative Effectiveness of a Phytotherapeutic Tea
NCT00872430 ·Status: COMPLETED ·Phase: PHASE2
-
The Inside Study: Oligosaccharides Versus Placebo in Functional Constipation
NCT04282551 ·Status: UNKNOWN ·Phase: NA